Trial
NCT04808570
A Study of TQ-B3525 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Collaborators
—
Condition
Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Intervention
TQ-B3525 tablets
Why stopped
The sponsor terminated the study due to the R\&D strategy change.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-29